MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,936 Cr | ₹1,778 Cr | ₹1,293 Cr | ₹1,110 Cr | ₹1,070 Cr |
What is the latest Total Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,936 Cr |
| Mar2025 | ₹1,778 Cr |
| Mar2024 | ₹1,293 Cr |
| Mar2023 | ₹1,110 Cr |
| Mar2022 | ₹1,070 Cr |
How is Total Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,936 Cr | 8.89 | |
| Mar2025 | ₹1,778 Cr | 37.50 | |
| Mar2024 | ₹1,293 Cr | 16.45 | |
| Mar2023 | ₹1,110 Cr | 3.78 | |
| Mar2022 | ₹1,070 Cr | - | |
Compare Total Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,921.1 Cr | -18.5% | -14.3% | 134.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -18.5% |
-14.3% |
134.5% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses